Log in to save to my catalogue

Real‐world data on ALK rearrangement test in Chinese advanced non‐small cell lung cancer (RATICAL):...

Real‐world data on ALK rearrangement test in Chinese advanced non‐small cell lung cancer (RATICAL):...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_202ab237e00e47c6a976722ca36d4c24

Real‐world data on ALK rearrangement test in Chinese advanced non‐small cell lung cancer (RATICAL): a nationwide multicenter retrospective study

About this item

Full title

Real‐world data on ALK rearrangement test in Chinese advanced non‐small cell lung cancer (RATICAL): a nationwide multicenter retrospective study

Publisher

United States: John Wiley & Sons, Inc

Journal title

Cancer Communications, 2024-09, Vol.44 (9), p.992-1004

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
Anaplastic lymphoma kinase (ALK) test in advanced non‐small cell lung cancer (NSCLC) can help physicians provide target therapies for patients harboring ALK gene rearrangement. This study aimed to investigate the real‐world test patterns and positive rates of ALK gene rearrangements in advanced NSCLC.
Methods
In this real‐world...

Alternative Titles

Full title

Real‐world data on ALK rearrangement test in Chinese advanced non‐small cell lung cancer (RATICAL): a nationwide multicenter retrospective study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_202ab237e00e47c6a976722ca36d4c24

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_202ab237e00e47c6a976722ca36d4c24

Other Identifiers

ISSN

2523-3548

E-ISSN

2523-3548

DOI

10.1002/cac2.12593

How to access this item